首页> 外文会议>International conference on data integration in the life sciences >Mining Anti-coagulant Drug-Drug Interactions from Electronic Health Records Using Linked Data
【24h】

Mining Anti-coagulant Drug-Drug Interactions from Electronic Health Records Using Linked Data

机译:使用链接数据从电子病历中挖掘抗凝药物相互作用

获取原文

摘要

By nature, healthcare data is highly complex and voluminous. While on one hand, it provides unprecedented opportunities to identify hidden and unknown relationships between patients and treatment outcomes, or drugs and allergic reactions for given individuals, representing and querying large network datasets poses significant technical challenges. In this research, we study the use of Semantic Web and Linked Data technologies for identifying potential drug-drug interaction (PDDI) information from publicly available resources, and determining if such interactions were observed using real patient data. Specifically, we apply Linked Data principles and technologies for representing patient data from electronic health records (EHRs) at Mayo Clinic as Resource Description Framework (RDF), and identify PDDIs for widely prescribed anti-coagulant Warfarin. Our results from the proof-of-concept study demonstrate the potential of applying such a methodology to study prescription trends based on gender and age as well as patient health outcomes.
机译:从本质上讲,医疗保健数据非常复杂且数量众多。一方面,它提供了前所未有的机会来识别患者与治疗结果之间的隐藏和未知关系,或给定个体的药物和过敏反应,代表和查询大型网络数据集提出了重大的技术挑战。在这项研究中,我们研究使用语义网和链接数据技术从可公开获得的资源中识别潜在的药物相互作用(PDDI)信息,并确定是否使用真实的患者数据观察到了这种相互作用。具体来说,我们应用链接数据的原理和技术,将Mayo诊所的电子健康记录(EHR)中的患者数据表示为资源描述框架(RDF),并为广泛处方的抗凝华法林确定PDDI。我们从概念验证研究中获得的结果表明,采用这种方法研究基于性别和年龄以及患者健康状况的处方趋势的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号